首页> 外文期刊>Urology >The Urinary Microbiome: Implications in Bladder Cancer Pathogenesis and Therapeutics
【24h】

The Urinary Microbiome: Implications in Bladder Cancer Pathogenesis and Therapeutics

机译:尿液微生物组:在膀胱癌发病机制和治疗中的影响

获取原文
获取原文并翻译 | 示例
           

摘要

Recent investigation has proven that the bladder is not sterile. However, the implications of this finding in the pathophysiology and management of urothelial cell carcinoma have not been fully described. In this review, we summarize the literature relating to the urinary and gastrointestinal microbiomes in the context of urothelial cell carcinoma. The bladder microbiome may relate to urothelial cell carcinoma pathogenesis/progression, act as a noninvasive and modifiable urinary biomarker and have implications in treatment using immunotherapy agents such as intravesical bacillus Calmette-Guerin. Investigators should continue to optimize techniques to characterize this intriguing new area of human health. (C) 2019 Elsevier Inc.
机译:最近的调查证明膀胱并不无菌。 然而,该发现在病理生理学和尿路上细胞癌的病理生理学和管理中的影响尚未得到充分描述。 在本综述中,我们总结了尿路上皮细胞癌的背景下与尿和胃肠道微生物有关的文献。 膀胱微生物组可以涉及尿路上细胞癌发病机制/进展,其作为非侵入性和可改性的尿生物标志物,并在使用免疫疗法如膀胱内芽孢菌植物植物中的免疫治疗剂来治疗。 调查人员应继续优化技术的特征,以表征这种有趣的人类健康新领域。 (c)2019年Elsevier Inc.

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号